Skip to main navigation
Skip to search
Skip to main content
King's College London Home
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Datasets
Impacts
Prizes
Search by expertise, name or affiliation
Cancer Imaging
Life Sciences & Medicine
Biomedical Engineering & Imaging Sciences
Overview
Fingerprint
Network
Profiles
(26)
Research output
(1156)
Projects
(130)
Activities
(53)
Student theses
(17)
Prizes
(14)
Research output
Research output per year
1988
2001
2012
2019
2020
2021
2022
2023
2024
45151
Citations
786
Article
114
Meeting abstract
56
Review article
49
Literature review
151
More
31
Chapter
31
Editorial
30
Letter
19
Conference paper
10
Comment/debate
6
Meeting Abstract
6
Poster abstract
5
Book
5
Abstract
2
Poster
2
Preprint
1
Conference contribution
1
Paper
1
Short survey
1
Featured article
Research output per year
Research output per year
2 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Poster
Search results
2022
Characteristics and survival of advanced non-small cell lung cancer (NSCLC) in young Black patients: a Guy’s Cancer Centre real-world study.
Hughes, D.
,
Kapiris, M.
,
Podvez Nevajda, A.
,
Stavraka, C.
,
Cook, G.
,
Josephs, D.
,
Ghosh, S.
,
Pintus, E.
,
Gennatas, S.
,
Ahmed, S.
,
Santis, G.
,
Ryanna, K.
,
Montes, A.
,
Smith, D.
,
Karapanagiotou, E.
,
Van Hemelrijck, M.
,
Spicer, J.
&
Georgiou, A.
,
Oct 2022
.
Research output
:
Contribution to conference types
›
Poster
›
peer-review
File
Malignant Neoplasm
100%
Patient
100%
Non Small Cell Lung Cancer
100%
Clinical Trial
66%
Prospective Cohort Study
33%
51
Downloads (Pure)
2019
PECan study, imaging PD-L1 in cancer: A tool for measuring response to immunotherapy?
Hughes, D.
,
Chand, G.
,
Josephs, D.
,
Harries, M.
,
Papa, S.
,
Spicer, J.
,
Ting, H. H.
,
Goh, V.
&
Cook, G.
,
2019
,
p. XI61
.
Research output
:
Contribution to conference types
›
Poster
›
peer-review
Open Access
Malignant Neoplasm
100%
Programmed Death-Ligand 1
100%
Patient
35%
Technetium-99
28%
Non Small Cell Lung Cancer
21%